Toward a Healthier Future Through Obesity Prevention and Care: The JAMA Summit Report on Obesity

Importance: Obesity is one of the most difficult challenges of the modern era, affecting more than 1 billion people worldwide. Nearly half of US adults and 1 in 5 US children meet the medical definition of having obesity, with major consequences for cardiometabolic, kidney, hepatic, pulmonary, musculoskeletal, reproductive, oncologic, and mental health. Obesity also carries social and economic harms through stigma, discrimination, and bias. Observations: Drivers of the obesity epidemic include changes in food production and consumption accompanied by social, economic, and technological shifts that reduce food preparation, disrupt sleep, and decrease physical activity. The burden of these changes is not equally distributed, with higher obesity prevalence among socioeconomically disadvantaged populations. Current prevention measures include nutrition standards, food and menu labeling, school meal policies, sugar-sweetened beverage taxes, community-based lifestyle programs, and public assistance efforts. The impact of these approaches has been inadequate. Contemporary clinical management recognizes obesity as a chronic disease characterized by genetic, biological, and behavioral susceptibilities. Access, affordability, tolerability, and the chronicity of use remain major challenges for all available obesity management strategies, including new glucagon-like peptide-1 receptor agonist therapies. Potential solutions require a coordinated, multisector response and include efforts to prevent obesity at the societal level, improve care of individuals with obesity, and strengthen research and innovation. Priority areas include improving the food and physical activity environment; strengthening communication and education; strengthening childhood obesity prevention; addressing health inequities; reducing stigma and bias; modernizing obesity care delivery; expanding access to lifestyle, healthy food, medication, and surgical interventions; and supporting long-term treatment adherence and maintenance. Proposed actions include new government policies on food production, labeling, marketing, and school nutrition; modernization of drug evaluation; payment reform to support comprehensive obesity treatment; development of multidisciplinary care models; incentives to promote cross-sector partnerships; and research to advance personalized prevention and treatment strategies. Conclusions and Relevance: The emergence of effective obesity management medications offers a significant opportunity to curb the prevalence of obesity. However, no single intervention will be enough. Sustained improvement will require addressing the underlying structural and environmental drivers of obesity, along with person-centered, multilevel strategies that simultaneously improve prevention, reduce stigma, and expand equitable access to evidence-based treatment. Coordinated action across government, health care systems, clinicians, payers, industry, schools, communities, and researchers will be essential to achieving long-term improvement.

Authors

Institutions

Publication Details

Journal
JAMA
Published
2026-11-17
DOI
https://doi.org/10.1001/jama.2026.19759
Citations
1
Primary Topic
Obesity, Physical Activity, Diet
Type
article
Field-Weighted Citation Impact
3.66
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Toward a Healthier Future Through Obesity Prevention and Care: The JAMA Summit Report on Obesity

Derek C. Angus, Shannon N. Zenk, Lindsay Dawson, B. Gabriel Smolarz et al.
1 citations
JAMA
Obesity, Physical Activity, Diet
3.66
article

Toward a Healthier Future Through Obesity Prevention and Care: The JAMA Summit Report on Obesity

Derek C. Angus, Shannon N. Zenk, Lindsay Dawson, B. Gabriel Smolarz, Johanna Ralston, Chiadi E. Ndumele, Hilary Kessler Seligman, Francesca L. Celletti, Alexis Ogdie, Fatima Cody Stanford, Dhruv S. Kazi, Beth Frates, Samuel Klein, Joseph F. Nadglowski, Wendy C. Whitehead, Rhonda E. Monroe, Joseph S. Ross, Linong Ji, William Timothy Garvey, Rekha B. Kumar, Deidra C. Crews, Louis J. Aronne, Kimberly Anne Gudzune, Gary D. Foster, Timothy S. Anderson, Anne Rentoumis Cappola, Julie M. Donohue, Nicolaas P. Pronk, Robert F. Kushner, Francisco J. Pasquel, Gregory J. Esper, Dariush Mozaffarian, Marion Nestle, Jennifer L. Pomeranz, Rexford S. Ahima, Jeffrey A. Huebner, Lee M. Kaplan, T. Joseph Mattingly, Naveed A. Sattar, David E Arterburn, Mary McGrae McDermott, David S. Ludwig, Jens Juul Holst, Rachel Louise Batterham, Lotte Bjerre Knudsen, Jamy D. Ard, Purnima Menon, Kim Boyd, John M. Jakicic, Jason Brett, Kirsten Bibbins-Domingo, Rachel Cox, JAMA Summit on Obesity, Michelle McRae, Hannah Park, John Magaña Morton
article en
1 citations

Abstract

Importance: Obesity is one of the most difficult challenges of the modern era, affecting more than 1 billion people worldwide. Nearly half of US adults and 1 in 5 US children meet the medical definition of having obesity, with major consequences for cardiometabolic, kidney, hepatic, pulmonary, musculoskeletal, reproductive, oncologic, and mental health. Obesity also carries social and economic harms through stigma, discrimination, and bias. Observations: Drivers of the obesity epidemic include changes in food production and consumption accompanied by social, economic, and technological shifts that reduce food preparation, disrupt sleep, and decrease physical activity. The burden of these changes is not equally distributed, with higher obesity prevalence among socioeconomically disadvantaged populations. Current prevention measures include nutrition standards, food and menu labeling, school meal policies, sugar-sweetened beverage taxes, community-based lifestyle programs, and public assistance efforts. The impact of these approaches has been inadequate. Contemporary clinical management recognizes obesity as a chronic disease characterized by genetic, biological, and behavioral susceptibilities. Access, affordability, tolerability, and the chronicity of use remain major challenges for all available obesity management strategies, including new glucagon-like peptide-1 receptor agonist therapies. Potential solutions require a coordinated, multisector response and include efforts to prevent obesity at the societal level, improve care of individuals with obesity, and strengthen research and innovation. Priority areas include improving the food and physical activity environment; strengthening communication and education; strengthening childhood obesity prevention; addressing health inequities; reducing stigma and bias; modernizing obesity care delivery; expanding access to lifestyle, healthy food, medication, and surgical interventions; and supporting long-term treatment adherence and maintenance. Proposed actions include new government policies on food production, labeling, marketing, and school nutrition; modernization of drug evaluation; payment reform to support comprehensive obesity treatment; development of multidisciplinary care models; incentives to promote cross-sector partnerships; and research to advance personalized prevention and treatment strategies. Conclusions and Relevance: The emergence of effective obesity management medications offers a significant opportunity to curb the prevalence of obesity. However, no single intervention will be enough. Sustained improvement will require addressing the underlying structural and environmental drivers of obesity, along with person-centered, multilevel strategies that simultaneously improve prevention, reduce stigma, and expand equitable access to evidence-based treatment. Coordinated action across government, health care systems, clinicians, payers, industry, schools, communities, and researchers will be essential to achieving long-term improvement.

JAMA
Wisconsin Department of Health Services (US), Northwestern University (US), Tufts University (US), University of Copenhagen (DK), Boston Children's Hospital (US), Beth Israel Deaconess Medical Center (US), University of Wisconsin–Madison (US), Harvard University (US), Johns Hopkins University (US), Kaiser Permanente Washington Health Research Institute (US), International Food Policy Research Institute (US), Emory University (US), Eli Lilly (United States) (US), University of Pittsburgh (US), University of California, San Francisco (US), Aarhus University (DK), Washington University in St. Louis (US), University of Utah (US), University of Alabama at Birmingham (US), Yale University (US), University of Illinois Chicago (US), Massachusetts General Hospital (US), World Health Organization (CH), Peking University People's Hospital (CN), University of Kansas Medical Center (US), World Obesity Federation (GB), Weill Cornell Medicine (US), Instacart (United States) (US), Wake Forest University Health Sciences (US), WW International, Inc. (United States) (US), Wake Forest University (US), HealthPartners (US), New York University (US), University of Glasgow (GB), University of Pennsylvania (US)
Good health and well-being, Reduced inequalities
Openalex Percentile: Top 15%
Obesity, Physical Activity, Diet
3.66
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon